
News
Home>News & Events>Presentations>CPAD>Collaborating for Cures Leveraging Global Public-Private Partnerships to Accelerate Biopharmaceuticals Development CAMD Presentation
65
Related Posts
-
The Choice of Outcome Parameters and Need for Distinct Assessment Tools with Regard to the Different Disease Stages in Alzheimer’s Disease (Video)
-
A Path to Accelerating Treatments for Neurodegenerative Diseases
-
CTAD, Harmonizing Regulatory Requirements to Benefit Alzheimer’s Disease Patients: Lessons learned from Critical Path Institute
-
RASAD – AD Biomarkers: Regulatory Science Path
-
CALBIO2012 – Role of Patient Advocacy Groups in Accelerating Drug Development